YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

AstraZeneca buys STL company

Posted online

AstraZeneca has acquired St. Louis-based vaccine bioconjugation specialist Omniose.

Omniose is now a wholly owned subsidiary within AstraZeneca's infectious disease unit.

“Omniose’s bioconjugation platform represents a differentiated approach to engineering conjugate vaccines and strengthens our ability to develop novel vaccines against serious bacterial infections,” said Benjamin Moutier, senior vice president, infectious disease at AstraZeneca.

Read more from Fierce Biotech.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
From The Ground Up: Schweitzer Church addition & renovations

This is a multi-phase project, with a new addition as well as renovations to the current church facility that include expanding the current parking lot, according to construction officials.

Most Read
Update cookies preferences